Clinical Trials Directory

Trials / Completed

CompletedNCT05108337

Superficial Cervical Plexus Block for Postoperative Chronic Pain

Ultrasound Guided Superficial Cervical Plexus Block for Chronic Pain After Craniotomy Via Suboccipital Retrosigmoid Approach: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
292 (actual)
Sponsor
Beijing Tiantan Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The incidence of postoperative chronic pain after craniotomy is high. Postoperative chronic pain seriously affects patient's quality of life. Compound local scalp nerve block is a good choice for analgesia after craniotomy. However, the scalp nerve block commonly cannot cover the area of suboccipital retrosigmoid approach craniotomy, leading to incomplete block. Superficial cervical plexus block (SCPB) is theoretically promising to solve the analgesia requirements of such surgical approach. At the same time, ultrasound guidance can not only accurately locate, ensure the effect of block and avoid accidental injury during puncture. The purpose of this study is to explore whether ultrasound-guided superficial cervical plexus block can safely and effectively reduce the incidence of chronic pain after craniotomy via suboccipital retrosigmoid approach.

Conditions

Interventions

TypeNameDescription
PROCEDURESuperficial cervical plexus blockUltrasound guidance will be used to determine the location of superficial cervical plexus nerve. The puncture will also be performed by ultrasound guidance, covered with opaque infusion dressing but performed with infusion of 10 ml 0.5% ropinacaine.
OTHERControl groupUltrasound guidance will be used to determine the location of superficial cervical plexus nerve. The puncture will also be performed by ultrasound guidance, covered with opaque infusion dressing but performed with infusion of 10 ml normal saline.

Timeline

Start date
2021-11-04
Primary completion
2023-11-22
Completion
2023-11-22
First posted
2021-11-04
Last updated
2024-01-23

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05108337. Inclusion in this directory is not an endorsement.